Itoh S, Katsuura G
Eur J Pharmacol. 1981 Nov 5;75(4):313-6. doi: 10.1016/0014-2999(81)90559-8.
Intracerebroventricular (i.c.v.) administration of cholecystokinin octapeptide (CCK-8) appeared to suppress the effects of L-DOPA and antagonize the actions of thyrotropin-releasing hormone (TRH). This was not only proved by the behavioral rating, but also by locomotor activity counting. thus, the sedative action of CCK-8 and the antagonizing effect of this peptide on the central actions of TRH were clearly demonstrated.
脑室内注射八肽胆囊收缩素(CCK-8)似乎可抑制左旋多巴的作用,并拮抗促甲状腺激素释放激素(TRH)的作用。这不仅通过行为评分得到证实,还通过运动活动计数得到证实。因此,CCK-8的镇静作用以及该肽对TRH中枢作用的拮抗作用得到了明确证明。